help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Théret, N.
Right arrow Articles by Clément, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Théret, N.
Right arrow Articles by Clément, B.
(American Journal of Pathology. 1998;153:945-954.)
© 1998 American Society for Investigative Pathology


Regular Articles

Differential Expression and Origin of Membrane-Type 1 and 2 Matrix Metalloproteinases (MT-MMPs) in Association with MMP2 Activation in Injured Human Livers

Nathalie Théret, Orlando Musso, Annie L'Helgoualc'h, Jean-Pierre Campion and Bruno Clément

From the Detoxication and Tissue Repair Unit, INSERM U456, Université de Rennes I, Rennes, France

Matrix metalloproteinase-2 (MMP2) activation is associated with basement membrane remodeling that occurs in injured tissues and during tumor invasion. The newly described membrane-type MMPs (MT-MMPs) form a family of potential MMP2 activators. We investigated the localization and steady-state levels of MT1-MMP and MT2-MMP mRNA, compared with those of MMP2 and tissue inhibitor of MMP-2 in 22 hepatocellular carcinomas, 12 liver metastases from colonic adenocarcinomas, 13 nontumoral samples from livers with metastases, 10 benign tumors, and 6 normal livers. MMP2 activation was analyzed by zymography in the same series. The expression of MT1-MMP mRNA and the activation of MMP-2 were increased in hepatocellular carcinomas, metastases, and cholestatic nontumoral samples. MT2-MMP mRNA was rather stable in the different groups. MT1-MMP mRNA levels, but not MT2-MMP mRNA, correlated with MMP-2 and tissue inhibitor of MMP-2 mRNA levels and with MMP2 activation. In situ hybridization showed that MT1-MMP mRNA was expressed in stromal cells, and MT2-MMP mRNA was principally located in both hepatocytes and biliary epithelial cells. Consistently, freshly isolated hepatocytes expressed only MT2-MMP mRNA, and culture-activated hepatic stellate cells showed high levels of MT1-MMP mRNA. These results indicate that in injured livers, MMP2 activation is related to a coordinated high expression of MMP2, tissue inhibitor of MMP-2, and MT1-MMP. Furthermore, the finding of a preferential expression of MT2-MMP in hepatocytes, together with our previous demonstration that the activation of stellate cell-derived MMP2 in co-culture requires interactions with hepatocytes (Am J Pathol 1997, 150:51–58), suggests that parenchymal cells might play a pivotal role in the MMP2 activation process.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Mazzocca, S. C. Sciammetta, V. Carloni, L. Cosmi, F. Annunziato, T. Harada, S. Abrignani, and M. Pinzani
Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells
J. Biol. Chem., March 25, 2005; 280(12): 11329 - 11339.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-W. Chen, S.-L. Yu, J. J. W. Chen, H.-N. Li, Y.-C. Lin, P.-L. Yao, H.-Y. Chou, C.-T. Chien, W.-J. Chen, Y.-T. Lee, et al.
Anti-Invasive Gene Expression Profile of Curcumin in Lung Adenocarcinoma Based on a High Throughput Microarray Analysis
Mol. Pharmacol., January 1, 2004; 65(1): 99 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Mertens, K. Steinmann, M. A. Alfonso-Jaume, A. En-Nia, Y. Sun, and D. H. Lovett
Combinatorial Interactions of p53, Activating Protein-2, and YB-1 with a Single Enhancer Element Regulate Gelatinase A Expression in Neoplastic Cells
J. Biol. Chem., July 5, 2002; 277(28): 24875 - 24882.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Musso, M. Rehn, N. Theret, B. Turlin, P. Bioulac-Sage, D. Lotrian, J.-P. Campion, T. Pihlajaniemi, and B. Clement
Tumor Progression Is Associated with a Significant Decrease in the Expression of the Endostatin Precursor Collagen XVIII in Human Hepatocellular Carcinomas
Cancer Res., January 1, 2001; 61(1): 45 - 49.
[Abstract] [Full Text]


Home page
GutHome page
B von Lampe, B Barthel, S E Coupland, E-O Riecken, and S Rosewicz
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
Gut, July 1, 2000; 47(1): 63 - 73.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Maatta, Y. Soini, A. Liakka, and H. Autio-Harmainen
Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis
Clin. Cancer Res., July 1, 2000; 6(7): 2726 - 2734.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Pei
Identification and Characterization of the Fifth Membrane-type Matrix Metalloproteinase MT5-MMP
J. Biol. Chem., March 26, 1999; 274(13): 8925 - 8932.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.